2012 POZ 100 Recognizes defeatHIV Investigators

2012 POZ 100 magazine cover

POZ, December 2012, The POZ 100

The influential HIV advocacy magazine POZ has released its 2012 POZ 100 list, which it devoted to individuals who are “Accelerating the end of AIDS”, and all three Martin Delaney Collaboratories are represented – defeatHIV, CARE and DARE.  Read below for their recognition of our defeatHIV investigators.

While there is still much work to be done in our pursuit of a cure, we are making progress and are excited about the re-energized focus on HIV cure efforts.  We thank POZ and the NIAID/NIH, through their Martin Delaney Collaboratory funding, for continuing to support our vital research.

From POZ

“From scientists and researchers making groundbreaking discoveries to the advocates and politicians on the front lines of the epidemic, this year’s list recognizes people who have made a significant contribution to speeding up the end of AIDS.  Through their efforts, the cure might be closer than you think.”

Keith Jerome, MD, PhD and Hans-Peter Kiem, MD

“Both of the Fred Hutchinson Cancer Research Center in Seattle, Jerome and Kiem are developing proteins known as endonucleases to target HIV.  They’re also collaborating with Sangamo BioSciences to further study the use of gene therapies to render the immune system resistant to the virus.”

Tae-Wook Chun, PhD

“A scientist at the National Institute of Allergy and Infectious Diseases, Chun and his colleagues were among the first to find HIV reservoirs, those long-lived, HIV-infected CD4 cells impervious to ARVs. That was in 1997; since then, he’s been heavily involved in researching was to eradicate them.”

Jim Mullins, PhD

“The professor of microbiology, medicine and laboratory medicine at the University of Washington is working to find an HIV vaccine.  He leads one of the two labs that did genetic analysis of the virus in the RV144 vaccine trial in Thailand, which showed some protection against HIV.”

Ann Woolfrey, MD

“A pediatric oncologist at Seattle Children’s Hospital, she specializes in bone-marrow transplants. She’s the lead investigator for many clinical trials of the Seattle Cancer Care Alliance, including a trial of a mechanism similar to one that cured Timothy Brown of HIV.”

Excerpts from POZ issue #184, published December 2012: The POZ 100 – Accelerating the End of AIDS